Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

OSL:BNOR - NO0010379266 - Common Stock

468.5 NOK
-2.5 (-0.53%)
Last: 9/8/2025, 10:46:34 AM
Fundamental Rating

4

Taking everything into account, BNOR scores 4 out of 10 in our fundamental rating. BNOR was compared to 63 industry peers in the Oil, Gas & Consumable Fuels industry. While BNOR is still in line with the averages on profitability rating, there are concerns on its financial health. BNOR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BNOR had negative earnings in the past year.
In the past year BNOR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BNOR reported negative net income in multiple years.
BNOR had a positive operating cash flow in each of the past 5 years.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of BNOR (-0.78%) is worse than 77.78% of its industry peers.
The Return On Equity of BNOR (-3.62%) is worse than 79.37% of its industry peers.
BNOR has a Return On Invested Capital (5.61%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BNOR is in line with the industry average of 9.83%.
Industry RankSector Rank
ROA -0.78%
ROE -3.62%
ROIC 5.61%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

With a decent Operating Margin value of 28.10%, BNOR is doing good in the industry, outperforming 65.08% of the companies in the same industry.
In the last couple of years the Operating Margin of BNOR has grown nicely.
Looking at the Gross Margin, with a value of 56.91%, BNOR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of BNOR has grown nicely.
Industry RankSector Rank
OM 28.1%
PM (TTM) N/A
GM 56.91%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

2

2. Health

2.1 Basic Checks

BNOR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BNOR has more shares outstanding than it did 1 year ago.
BNOR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BNOR is higher compared to a year ago.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of BNOR is 9.10, which is on the high side as it means it would take BNOR, 9.10 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.10, BNOR is in line with its industry, outperforming 46.03% of the companies in the same industry.
A Debt/Equity ratio of 1.50 is on the high side and indicates that BNOR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.50, BNOR is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 9.1
Altman-Z N/A
ROIC/WACC0.67
WACC8.38%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

BNOR has a Current Ratio of 1.41. This is a normal value and indicates that BNOR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BNOR (1.41) is comparable to the rest of the industry.
A Quick Ratio of 1.27 indicates that BNOR should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.27, BNOR perfoms like the industry average, outperforming 58.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.27
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for BNOR have decreased strongly by -560.00% in the last year.
The Revenue has grown by 9.88% in the past year. This is quite good.
BNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.10% yearly.
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%52.34%

3.2 Future

The Earnings Per Share is expected to grow by 30.91% on average over the next years. This is a very strong growth
Based on estimates for the next years, BNOR will show a quite strong growth in Revenue. The Revenue will grow by 8.69% on average per year.
EPS Next Y311.71%
EPS Next 2Y113.29%
EPS Next 3Y61.31%
EPS Next 5Y30.91%
Revenue Next Year49.64%
Revenue Next 2Y31.15%
Revenue Next 3Y17.93%
Revenue Next 5Y8.69%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -100 -200 -300

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNOR. In the last year negative earnings were reported.
BNOR is valuated cheaply with a Price/Forward Earnings ratio of 6.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BNOR indicates a rather cheap valuation: BNOR is cheaper than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, BNOR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.58
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BNOR.
80.95% of the companies in the same industry are more expensive than BNOR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.62
EV/EBITDA 5.58
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

BNOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BNOR's earnings are expected to grow with 61.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y113.29%
EPS Next 3Y61.31%

0

5. Dividend

5.1 Amount

BNOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (9/8/2025, 10:46:34 AM)

468.5

-2.5 (-0.53%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-10 2025-07-10/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners33.4%
Inst Owner ChangeN/A
Ins Owners1.13%
Ins Owner ChangeN/A
Market Cap12.42B
Analysts81.43
Price Target620.5 (32.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-62.89%
Min EPS beat(2)-71.31%
Max EPS beat(2)-54.48%
EPS beat(4)0
Avg EPS beat(4)-147.45%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)0
Avg EPS beat(8)-120.71%
EPS beat(12)3
Avg EPS beat(12)-79.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.71%
Min Revenue beat(2)-33.43%
Max Revenue beat(2)-1.98%
Revenue beat(4)0
Avg Revenue beat(4)-14.09%
Min Revenue beat(4)-33.43%
Max Revenue beat(4)-1.98%
Revenue beat(8)2
Avg Revenue beat(8)-7.17%
Revenue beat(12)4
Avg Revenue beat(12)-4.24%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.97%
PT rev (3m)-16.01%
EPS NQ rev (1m)-12.73%
EPS NQ rev (3m)-39.79%
EPS NY rev (1m)-30.09%
EPS NY rev (3m)-30.09%
Revenue NQ rev (1m)2.25%
Revenue NQ rev (3m)-19.16%
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-17.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.58
P/S 1.56
P/FCF 7.62
P/OCF 4.04
P/B 1.62
P/tB 1.98
EV/EBITDA 5.58
EPS(TTM)-13.86
EYN/A
EPS(NY)71.2
Fwd EY15.2%
FCF(TTM)61.45
FCFY13.12%
OCF(TTM)116
OCFY24.76%
SpS301.14
BVpS289.77
TBVpS236.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.78%
ROE -3.62%
ROCE 7.28%
ROIC 5.61%
ROICexc 6.57%
ROICexgc 6.94%
OM 28.1%
PM (TTM) N/A
GM 56.91%
FCFM 20.41%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexcg growth 3Y15.21%
ROICexcg growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 9.1
Debt/EBITDA 2.81
Cap/Depr 78.38%
Cap/Sales 18.11%
Interest Coverage 1.94
Cash Conversion 75.22%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.27
Altman-Z N/A
F-Score5
WACC8.38%
ROIC/WACC0.67
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y311.71%
EPS Next 2Y113.29%
EPS Next 3Y61.31%
EPS Next 5Y30.91%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%52.34%
Revenue Next Year49.64%
Revenue Next 2Y31.15%
Revenue Next 3Y17.93%
Revenue Next 5Y8.69%
EBIT growth 1Y-10.29%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year255.42%
EBIT Next 3Y53.78%
EBIT Next 5Y23.2%
FCF growth 1Y-30.87%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y-39.47%
OCF growth 3Y84.65%
OCF growth 5Y4.46%